SYDNEY — A Cape Breton health-care advocate is welcoming the province’s decision to cover a new line of hepatitis C drugs.
Christine Porter, who runs the Ally Centre of Cape Breton in Sydney,
said any move to lower prescription drug costs for the marginalized is a
step in the right direction.
She said the island is home to the highest per capita rates of the disease in both the province and the country.
“It’s a great thing when the government covers medications for any
disease, especially with hepatitis C; the cost is exorbitant unless you
have a really, really good medical plan,” said Porter.
Labels: Canada, HOLKIRA PAK, Nova Scotia, Pharmacare coverage